DETECTING DISEASE EARLY
FOR TOMORROW’S HEALTH
developing Tomorrow's innovative diagnostics
Hummingbird Diagnostics is developing liquid biopsy diagnostics for early disease detection, personalized medicine, and lifetime health monitoring based on highly disease-specific miRNA biomarkers.
mirna-based LIQUID BIOPSY DIAGNOSTICS
UPDATES ON THE LATEST DEVELOPMENTS
DX Pipeline
Explore our ground-breaking pipeline of proprietary, miRNA-based diagnostic tests from blood.
PUBLICATIONS
Learn more about genomic biomarkers and read publications from the biomarker field.